Prime Medicine, Inc.
- CIK: 0001894562
- EIN: 00-0000000
- Business address: 21 ERIE ST., CAMBRIDGE, Massachusetts, 02139
Information
Mailing address
21 ERIE ST., CAMBRIDGE, Delaware, 02139Phone
617-465-0013State location
MassachusettsState of incorporation
DelawareFiscal year end
December 31SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)Filings
N/A
About Prime Medicine, Inc.
Prime Medicine, Inc. (CIK: 0001894562) is an American company incorporated in the state of Massachusetts. Head office is located at 21 ERIE ST., CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Prime Medicine, Inc. is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Marrazzo Jeffrey D | 0001631262 | May-10-2023 | director |
| Alphabet Inc. | 0001652044 | May-08-2023 | 10 percent owner |
| GV 2019 GP, L.L.C. | 0001845038 | May-08-2023 | 10 percent owner |
| GV 2019 GP, L.P. | 0001845039 | May-08-2023 | 10 percent owner |
| GV 2019, L.P. | 0001845041 | May-08-2023 | 10 percent owner |
| GV 2021, L.P. | 0001861202 | May-08-2023 | 10 percent owner |
| GV 2021 GP, L.L.C. | 0001861206 | May-08-2023 | 10 percent owner |
| GV 2021 GP, L.P. | 0001861216 | May-08-2023 | 10 percent owner |
| FMR LLC | 0000315066 | Oct-19-2022 | 10 percent owner, other: See Remark 1 |
| CRANDELL KEITH | 0001219039 | Oct-19-2022 | 10 percent owner |
| NELSEN ROBERT | 0001219042 | Oct-19-2022 | director, 10 percent owner |
| GILLIS STEVEN | 0001229592 | Oct-19-2022 | 10 percent owner |
| Foster-Cheek Kaye I | 0001312622 | Oct-19-2022 | director |
| Burow Kristina | 0001569248 | Oct-19-2022 | 10 percent owner |
| Schenkein David P | 0001578200 | Oct-19-2022 | director |
| Gottesdiener Keith Michael | 0001615856 | Oct-19-2022 | director, officer: See Remarks |
| Liu David R. | 0001664439 | Oct-19-2022 | 10 percent owner |
| Alenson Carman | 0001688865 | Oct-19-2022 | officer: See Remarks |
| Brudnick Richard | 0001692359 | Oct-19-2022 | officer: Chief Business Officer |
| LEE ANN L. | 0001723629 | Oct-19-2022 | officer: Chief Technical Officer |
| ARCH Venture Fund X, L.P. | 0001757011 | Oct-19-2022 | 10 percent owner |
| ARCH Venture Fund X Overage, L.P. | 0001757017 | Oct-19-2022 | 10 percent owner |
| ARCH Venture Partners X Overage, L.P. | 0001768905 | Oct-19-2022 | 10 percent owner |
| ARCH Venture Partners X, LLC | 0001769012 | Oct-19-2022 | 10 percent owner |
| Kelly Michael Aaron | 0001769668 | Oct-19-2022 | director |
| ARCH Venture Partners X, L.P. | 0001782583 | Oct-19-2022 | 10 percent owner |
| Duffield Jeremy | 0001922590 | Oct-19-2022 | officer: Chief Scientific Officer |
| Chung Wendy | 0001922605 | Oct-19-2022 | director |
| Goldwasser Meredith | 0001922606 | Oct-19-2022 | officer: SVP, Strategy & Corporate Ops. |
| Cahill Thomas | 0001922939 | Oct-19-2022 | director |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Prime Medicine, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001193125-25-056122 (34 Act) Size: KB |
Mar-18-2025 | 25746486 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000014 ( Act) Size: 0 KB |
Mar-04-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000012 ( Act) Size: 0 KB |
Mar-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000010 ( Act) Size: 0 KB |
Mar-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000008 ( Act) Size: 0 KB |
Mar-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000006 ( Act) Size: 0 KB |
Mar-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000004 ( Act) Size: 0 KB |
Mar-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-25-000002 ( Act) Size: 0 KB |
Mar-03-2025 | |
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001628280-25-008885 (33 Act) Size: KB |
Feb-28-2025 | 25682858 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001628280-25-008884 (34 Act) Size: KB |
Feb-28-2025 | 25682824 |
| 8-K | Document | Current report filing Acc-no: 0001628280-25-008873 (34 Act) Size: KB |
Feb-28-2025 | 25682800 |
| SCHEDULE 13G/A | Document | Acc-no: 0001493152-25-006876 (34 Act) Size: KB | Feb-14-2025 | 25628935 |
| 8-K | Document | Current report filing Acc-no: 0001628280-25-001244 (34 Act) Size: KB |
Jan-13-2025 | 25524879 |
| EFFECT | Document | Acc-no: 9999999995-24-003900 (33 Act) Size: KB | Dec-20-2024 | 241569588 |
| CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-24-281271 ( Act) Size: KB |
Dec-18-2024 | |
| UPLOAD | Document | Acc-no: 0000000000-24-013902 ( Act) Size: KB | Dec-17-2024 | |
| S-3 | Document | Registration statement for specified transactions by certain issuers Acc-no: 0001628280-24-051126 (33 Act) Size: KB |
Dec-13-2024 | 241546871 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-24-000049 ( Act) Size: 0 KB |
Dec-09-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-24-000048 ( Act) Size: 0 KB |
Dec-09-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001894562-24-000047 ( Act) Size: 0 KB |
Dec-09-2024 |
Recent 20 filings. View all Prime Medicine, Inc. filings
Reviews
Pelisari
young lad who new his job ansered questions and new what was best for me.
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Catherine
Thanks I look forward to using the product to improve my skin tone
Frequently Asked Questions
Tags:
- Prime Medicine, Inc. overview
- Prime Medicine, Inc. job
- Prime Medicine, Inc. stock
- Prime Medicine, Inc. ownership
- Prime Medicine, Inc. CEO
- Prime Medicine, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Bonus Biogroup Ltd.
Update: May 10, 2025
Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 